ClinicalTrials.gg
Not yet recruitingNCT06797063BEST4BabyUpdated Nov 9, 2026

Breastfeeding Education Support Tool

An interventional study of BEST4Baby and Usual Care in Breastfeeding, Exclusive, Infant Development and Infant Growth, sponsored by Thomas Jefferson University. Not yet recruiting at 1 site in India. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Thomas Jefferson University · Not applicable, Interventional, and Prevention

How we know

Updated Nov 9, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
336
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 11 studies in Breast Feeding with a site in India — 2 open to participants now, 2 under way, none of them phase 3. Breast Feeding · India.

Started
2026
the only one that year
No phase
6 of 11
2 open now
Registered
11th of 11
by date
Lead sponsor
2 of 11
Thomas Jefferson University

Among the 11 studies in Breast Feeding with a site in India, this one is the only one that started in 2026, is one of 6 with no phase, and was the 11th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

2 of the 11 studies in Breast Feeding with a site in India are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in India have not opened yet or have stopped. Only those recruiting at a site in India →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Breast Feeding with a site in India, or all of them as a file.
02

Study summary

The proposed project seeks to evaluate the effectiveness and implementation of the Breastfeeding Education Support Tool for Baby (BEST4Baby) intervention, an mHealth-supported community-based peer counselor breastfeeding intervention for mothers in India. Given that rates of optimal infant feeding practices have remained stagnant over the past two decades in India, and that India is the most populous country and icontributes one-fifth of all global live births, this project could have major global health implications if the intervention is found to improve maternal breastfeeding practices and infant clinical outcomes. The project will also provide evidence needed to adopt BEST4Baby nationally and in other low resource communities.

03

Conditions studied

  • Breastfeeding, Exclusive
  • Infant Development
  • Infant Growth
  • Breast Feeding

Browse trials for

Keywords

  • breastfeeding
  • India
  • infant feeding
  • peer counselors
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • at least 18 years of age,
  • pregnant and 20-27 weeks of gestation at study enrollment,
  • singleton pregnancy,
  • no major antepartum complications,
  • living in a research site,
  • planning to deliver in the cluster area,
  • capable of giving ,
  • willing to be visited by a PC and research personnel for up to 12 months post-delivery.

Exclusion criteria

Exclusion Criteria:

comorbidities impacting breastfeeding,

- severe psychological illness that could interfere with consent and study participation. Following a live birth, participants will remain eligible to continue in the study unless the mother or infant experiences: illness or clinical complications warranting prolonged hospitalization, stillbirth, low birth weight (\< 2500 g), congenital abnormality, or neonatal death.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
336 participants (estimated)

Study arms

  • Other
    Control

    Participants in the control clusters will continue with local practice for antenatal breastfeeding support and referral to facilities. It is expected that they will receive routine health education recommended by the Indian national health system during the prenatal and postnatal period.

    Behavioral: Usual Care

  • Experimental
    BEST4Baby

    BEST4Baby consists of prenatal and post-delivery breastfeeding education and support for mothers provided by community-based peer counselors who are trained in a modified 5-day WHO/UNICEF Breastfeeding Counselling Course and supported by an mHealth application.

    Behavioral: BEST4Baby

Interventions

  • BehavioralBEST4Baby

    BEST4Baby consists of prenatal and post-delivery breastfeeding education and support for mothers provided by community-based peer counselors who are trained in a modified 5-day WHO/UNICEF Breastfeeding Counselling Course and supported by an mHealth application.

  • BehavioralUsual Care

    Participants in the control clusters will continue with local practice for antenatal breastfeeding support and referral to facilities. It is expected that they will receive routine health education recommended by the national health system during the prenatal and postnatal period and offered through PHC and community level workers, including ASHAs. ASHAs may visit a woman after delivery to provide lactation support, as needed, with visits ceasing at 42 days post-delivery. Breastfeeding mothers requiring advanced lactation support may be referred to a community subcenter for care with more skilled clinicians.

06

What researchers measure

Primary outcomes

  1. exclusive breastfeeding at 6 months

    proportion of infants exclusively breastfed at 6 mo as measured with the infant feeding behavior questionnaire. EBF will be defined as receiving breast milk as the only source of nourishment for the first 6 mo of life, except for oral rehydration solution, vitamins, medicines.

    Time frame: 6 months

  2. Infant growth velocity

    mean change in length from birth to 6 months, and birth to 12 months

    Time frame: 6 months and 12 months

  3. Infant cognitive development

    mean Bayley Scales of Infant and Toddler Development cognitive domain scores at 12 months

    Time frame: 12 months

07

Study locations

1 site
  • KLE Univeristy
    Belagavi, Karnataka 19107, India
08

References and documents

Individual participant data

Plan to share: Yes — The survey, anthropometric measurements, and neurodevelopment assessment data will be shared.

Supporting information: Study protocol, Informed consent form

Time frame: All de-identified data will be available upon either publication of related work or completion of the project. The data will be available for at least 10 years after the funding period.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Sep 2029, 33 months later.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 33 months is above that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Dec 2026, on Nov 9, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2025
First posted
Jan 28, 2025
StartEst.
Dec 1, 2026was Sep 2026
Primary completionEst.
Sep 1, 2029
CompletionEst.
Sep 1, 2029
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 1, 2026→Dec 1, 2026
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Start date Sep 1, 2026→Dec 1, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06797063
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), KLE University Jawaharlal Nehru Medical College, Benten Technologies, Inc.
Responsible party
Sponsor
First posted
Jan 28, 2025
Start date
Dec 1, 2026 (estimated)
Primary completion
Sep 1, 2029 (estimated)
Completion
Sep 1, 2029 (estimated)
Last update
Nov 9, 2026

Study contacts

Vanessa Short, PhD, MPH
Contact
vanessa.short@jefferson.edu
412-352-1226
Parth Lalakia
Contact
parth.lalakia@jefferson.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion